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Abstract 
Objective:  
To evaluate the long-term (>5 years) health-related quality of life outcomes following 
radical cystectomy, comparing Indiana pouch (IP), neobladder (NB), and ileal conduit 
(IC). 
 
Materials and Methods:  
The departmental radical cystectomy database was queried to identify patients who 
underwent radical cystectomy and urinary diversion for bladder cancer between 1991 
and 2009 and had not died. Three hundred patients were identified and sent the 
validated Bladder Cancer Index (BCI) instrument. 
 
Results:  
A total of 128 (43%) of the patients completed the survey.   When adjusted for gender, 
age at surgery, surgeon, and time since surgery, IC and IP patients had significantly 
better urinary function than NB patients (p=0.0013). Sexual bother was less in NB than 
IP (p=0.0387). Among males ≥ 65 years of age, IC patients had significantly better 
urinary function (p=0.0376) than NB patients (91.6 vs. 49.4, respectively). Among males 
< 65 years of age, IC and IP patients (76.0 and 82.8, respectively) had significantly 
better urinary function than NB patients (50.7) (p=0.0199). Among females greater than 
65 years, bowel bother was significantly better (p=0.0095) for IC patients than IP 
patients (44.8 vs. 69.5, respectively). 
 
Conclusions: 
Urinary diversion type after radical cystectomy affects health-related quality of life 
(HRQOL) differently in long-term survivors.  Age and gender at surgery influenced 
HRQOL based on diversion procedure. Urinary function but not urinary bother were 
significantly better in IC and IP compared to NB diversions.  Prospective longitudinal 
studies using validated HRQOL tools will further help guide preoperative diversion 
choice decisions between patient and surgeon. 
 
Introduction 
 
Approximately 74,000 new cases of bladder cancer are diagnosed annually in the United 
States(1). Radical cystectomy (RC) with urinary diversion is performed for muscle 
invasive disease, high-risk nonmuscle invasive tumors such as high grade T1 with 
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carcinoma in situ (CIS), early recurrence of high-grade T1 tumors, and BCG failures 
including BCG refractory CIS disease (2, 3). Annually, over 7,000 patients are estimated to 
undergo RC with diversion in the United States(4).  These patients are currently 
counseled through surgeon experience and the limited data available that suggest 
benefits of certain diversions over others. Although RC is associated with improved 
overall survival, it can affect health-related quality of life (HRQOL) with regard to urinary, 
bowel, and sexual function (5-8). 
 
Prior to surgery, patients are typically presented with three options for urinary diversion 
including continent (i.e. Indiana pouch (IP) or neobladder (NB)) and incontinent diversion 
(ileal conduit (IC)).  Current literature has conflicting and inconclusive results regarding a 
superior diversion type in terms of quality of life.  Each diversion type poses disparate 
benefits and drawbacks.  The IP provides a continent option without the need for urethral 
utilization; however, it also is recognized to have the highest incidence of Clavien grade 
I-II complications(9). NB provides daytime continence and physical normality, but it is 
associated with nocturnal enuresis and the potential need for urethral catheterization.(9). 
As an incontinent option, the IC is associated with the lowest incidence of perioperative 
complications; however, it provides the least degree of lifestyle normalcy(9).  Most of the 
quality of life data comparing these diversion types are limited by short follow-up, which 
is usually within 12 months (10).  This has resulted in a paucity of literature comparing the 
long-term HRQOL outcomes based on diversion type.  It remains unclear which 
diversion would provide the best HRQOL over the long term to meet the needs of 
individual patients. 
 
The primary objective of this study is to evaluate the long-term HRQOL following RC, 
comparing IP, NB, and IC.  These data could provide useful information when 
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counseling patients regarding which urinary diversion may be their best option in the 
long term. 
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Methods 
 
After obtaining Institutional Review Board approval, the Indiana University departmental 
bladder cancer database was queried to identify patients who underwent RC and urinary 
diversion for bladder cancer between 1991 and 2009.  Urinary diversions were 
performed as previously reported(11-13) with vescica ileale Padovana (VIP) , Studer, or 
Hautmann NBs. IP is a detubularized folded right colon pouch with 10cm of terminal 
ileum used as an efferent catheterizable channel. This limb was tapered using a GIA 
stapler over a 12-french red rubber catheter. Continence was improved by plication 
stitches at the ileocecal valve.  Folding the colon pouch increased the compliance and 
capacity. Patients were eligible to be included if they had the following: at least five years 
of follow-up after RC, alive based on medical records or Social Security death index data, 
and had a current address in the medical record.  Based upon these criteria, 300 
patients were identified.  Surveys were mailed to patients with a stamped return 
envelope for survey return.  Patients were also offered a secure online portal to 
complete the survey if they preferred.  A total of 128 (43%) of the patients completed the 
survey.  The survey consisted of the Bladder Cancer Index (BCI) instrument.(14, 15) The 
BCI is a validated HRQOL instrument with disease-specific items aimed at determining 
urinary, bowel, and sexual domains of function and bother. The BCI is scored on a scale 
of 0 to 100, with higher numbers representing better HRQOL outcomes.  Clinical, 
demographic, and pathologic characteristics were extracted for each patient using our 
institutional database. 
 
ANOVA was used for continuous variable comparison between groups, and chi-squared 
or Fisher’s exact tests were used for categorical variables. ANCOVA was used to 
examine differences in the six BCI subscales among types of diversion, adjusting for 
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gender, surgeon, age at surgery, and time from surgery to survey. Final pathological 
characteristics were not included for adjustments, since these data are not available 
during pre-operative patient counseling for diversion type. Since age and gender were 
highly associated with type of diversion, sub-analyses were performed including only 
males < 65 years, males ≥ 65 years, and females ≥ 65 years. The decision to stratify 
outcomes at age 65 was based on previously published literature(16). A sub-analysis was 
unable to be performed on females under 65 years because only one had a NB, and 
none had an IC. Sexual function in females ≥ 65 years was unable to be evaluated due 
to absence of survey response to sexual function-specific questions. For all analyses 
with a significant diversion type effect, a pair-wise comparison was performed to 
determine which diversion significantly differed. When pair-wise comparisons were made, 
Hochberg’s step-up Bonferroni adjustment for multiple comparisons was used.  All 
statistical tests were two-sided, and SAS version 9.4 (SAS, Cary, NC, USA) was used 
for the analysis. 
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 Results  
 
Of the 128 respondents, 102 (80%) were male. The mean (SD) age at surgery was 62 
years; the range was 28-82 years. The mean (SD) time from surgery to survey was 11 
years, with a minimum follow-up of 5.9 years and maximum of 23.9 years. Forty-nine 
patients underwent a NB.  Twenty-four (50%) underwent a VIP, 20 (42%) underwent a 
Studer, and 4 (8%) underwent a Hautmann neobladder . Both gender and age were 
significantly associated with type of diversion (p<0.0001). Females were more likely to 
have IP than NB or IC (p<0.0001). IC patients were significantly older than NB and IP 
patients (p<0.0001). Unadjusted urinary function scores were highest in IP patients, 
p<0.0001.  Pathological stage and lymph node involvement were not significantly 
different between diversion types. Patient, pathological characteristics, and unadjusted 
BCI outcomes were shown in Table 1. 
 
The multivariable results, adjusting for gender, age at surgery, surgeon and time from 
surgery to survey are presented in Table 2. There was a significant difference between 
types of diversion and urinary and sexual function. IC and IP patients had significantly 
better urinary function than NB patients (p=0.0013). NB had significantly less sexual 
bother than IP (p=0.0387). 
 
Figure 1A, 1B, and 1C display the adjusted means based on gender and age (< or ≥65 
years old). These statistical differences are summarized in Supplemental Table 1. 
Among males ≥ 65 years of age, IC patients had significantly better urinary function than 
NB patients (p=0.0376; 91.6 vs. 49.4, respectively). Among males < 65 years of age, IP 
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patients (82.8) had significantly better urinary function than NB patients (50.7) 
(p=0.0199). Male urinary function differences by age are summarized in Figure 2.  
 
There was not an overall significant difference in bowel function or bother between 
diversion types.  In the sub-analysis, differences were noted among females greater 
than 65 years. For example, IC patients had significantly less bowel bother (91.7) than 
IP (69.0) patients. However, these were small sample sizes (n=9 and n=5, respectively). 
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Discussion 
 
To our knowledge, the cohort studied provides the longest follow-up for reported HRQOL 
for bladder cancer survivors. We report that urinary function was better overall in IP and 
IC patients compared with NB patients. There were differences in outcomes based on 
age and gender. Older males with IC had better urinary function than older men with NB.  
In younger men, IP patients had significantly better urinary function than NB patients.  
These results were statistically significant and also likely demonstrate clinical 
significance, with a score difference of 25-40 points out of 100. BCI urinary function 
questions focus primarily on urinary leakage.  While leakage can occur from IP stomas 
or poor fitting ostomy devices for IC, these are more rare events than leakage from NB(6, 
9-10).  This likely accounts for the difference in urinary function score between diversions.  
Despite worse urinary function or leakage in NB, urinary bother was not significantly 
different between diversions.  In the BCI, a portion of the bother component is reflected 
in question 9a, which relates to affecting social activity.  This certainly could be the most 
important question to consider in regards to HRQOL after RC.  This urinary bother 
question evaluated how often the urinary diversion limited activity with friends.  These 
data are depicted in Supplemental Figure 1.  Regardless of diversion type, most 
patients answered with ‘not at all’ or ‘a little bit’ bothered (p=0.10).  This emphasizes the 
need to consider both function and bother in HRQOL analyses to provide a more 
complete description. For example, the NB had worse urinary function mainly due to 
leakage, but the bother domain suggested this was not a significant concern.  Sexual 
bother was better in NB than IP. This could be attributed to higher rates of nerve-sparing 
during cystectomy with NB. Bowel bother differences were likely related to the relocation 
the ileocecal valve away from the gastrointestinal tract in IP patients(17). 
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Our findings differ from previous reported HRQOL studies.  This may be partially 
explained by their shorter follow-up time(10, 18-20). A recent review of non-randomized 
studies using other validated HRQOL tools (SF-36, EORT QLQ-C30 and FACT BL) 
comparing NB to IC found that 16 studies reported no difference between the two 
diversions, four studies that reported NB was superior to IC, and a single study indicated 
that IC had better HRQOL outcomes than NB(21).  Of note, however, two of the reviewed 
studies also reported better HRQOL outcomes in young, fit NB patients(22, 23).  This 
review concluded that NB was marginally better than IC, particularly in younger, fitter 
patients(21). The results of our study contrast with their findings. Specifically, we found 
that urinary function was better for IC comparted to NB in the overall adjusted cohort as 
well as both male group subgroups (<65 and ≥65 years old). Additionally, we found that 
IP had the highest urinary function in the overall adjusted cohort and younger male sub-
group. 
 
There is a paucity of literature detailing HRQOL outcomes following cutaneous continent 
urinary reservoir, such as the IP, following RC.  One prospective study using the SF-36 
instrument reported that patients with cutaneous continent urinary reservoir diversions 
had return of HRQOL back to baseline at one year after surgery, compared to IC scores 
that declined after surgery(24).  However, the SF-36 instrument does not evaluate bladder 
cancer-specific outcomes such as urinary function and bother, a finding that represents 
a significant limitation to the study.  Our study demonstrates minimal long-term 
differences in urinary function and bother between IP and IC patients. 
 
Several limitations should be considered.  Patients were treated at a high-volume tertiary 
care center with a large experience with IP diversion.  The results may not be 
generalizable to centers that are less familiar with cutaneous continent urinary reservoir 
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diversions. There was likely a selection bias in this retrospective, cross-sectional design 
with only a 43% patient response rate.  However, this response is similar to that in 
previous studies with shorter follow-up. (9,10) Short-term complications have been 
previously reported(9); thus, they were not reported or statistically controlled in this 
analysis. In addition, short-term complications may not be relevant to this cohort that has 
a mean follow-up of ten years.  However, in this mail-based survey we are unable to 
adjust to for long-term complications (i.e. incisional hernia, stones, infections, etc,) which 
may have biased our results.  Moreover, this was a long-term survivor group of bladder 
cancer patients.  It is unclear how these results would compare to those who died of 
their disease.  Results may reflect a “healthy worker” effect(25) and therefore may not be 
valid in patients without long-term survival. Furthermore, our cross-sectional assessment 
of HRQOL does not allow us to evaluate how these scores change over time.  However, 
we are currently performing a prospective study to understand any such temporal 
changes.  The BCI is a bladder cancer-specific instrument; therefore, we cannot 
comment on other aspects of HRQOL, such as physical and emotional function. It may 
be difficult to determine which diversion has superior HRQOL when function and bother 
are not congruent, such as our finding of the urinary function and bother.  
Additionally, the BCI has only been validated in IC and NB diversions. However, 
previous publications have reported its use in continent cutaneous urinary 
diversions(26,27). Nevertheless, the strength of the BCI is its validation in patients with 
bladder cancer(15). 
 
These limitations notwithstanding, our findings have several relevant clinical implications 
regarding patient counseling prior to RC and urinary diversion. First, males <65 years of 
age should be equally counseled about IP or IC as an alternative to NB in terms of 
urinary function. Second, older women with preoperative bowel issues may benefit from 
Page 11 of 19
IC rather than IP.  Regardless, any diversion decision should be made with a patient-
centered approach with careful consideration of the individual patient’s characteristics 
and surgeon’s ability.  Future studies based on preoperative baseline characteristics and 
HRQOL scores could help elucidate the ideal choice for a patient during preoperative 
counseling.  We plan to study HRQOL in patients with RC in a longitudinal prospective 
fashion. 
 
We conclude that urinary diversion type after RC affects HRQOL differently in long-term 
survivors.  Age and gender at surgery were associated with HRQOL based on diversion 
choice. Urinary function but not urinary bother were significantly better in IC and IP 
compared to NB diversions. Prospective longitudinal studies using validated HRQOL 
tools will further help guide preoperative diversion choice decisions between patient and 
surgeon.  
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Figure 1A: Neobladder (n=13)† [blue], Ileal Conduit (n=17) [red], Indiana Pouch 
(n=15) [green].  
†Neobladder has significantly worse urinary function than ileal conduit. 
 
Bladder Cancer Index for males ≥ 65 years of age at surgery, adjusting for age at 
surgery, surgeon, and time from surgery to survey 
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Figure 1B: Neobladder (n=34)‡ [blue], Ileal Conduit (n=17) [red], Indiana Pouch 
(n=15) [green]. †Neobladder has significantly worse urinary function than ileal 
conduit.  
‡Neobladder has significantly worse urinary function than both ileal conduit and 
Indiana pouch. 
 
Bladder Cancer Index for males < 65 years of age at surgery, adjusting for age at 
surgery, surgeon, and time from surgery to survey 
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Figure 1C: Ileal Conduit (n=9) [blue], Indiana Pouch (n=5) [red].  
*Bowel bother was significantly worse in IP than IC 
** Sexual function data absent due to lack of survey response to sexual function-
specific questions in female ≥ 65 years. 
 
Bladder Cancer Index for females ≥ 65 years of age at surgery, adjusting for age 
at surgery, surgeon, and time from surgery to survey 
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Figure 2: <65 years [blue], ≥ 65 years [red]. 
†For men ≥65 years, neobladder has significantly worse urinary function than 
ileal conduit. In men <65 years old, neobladder had worse urinary function than 
Indiana pouch and ileal conduit. 
 
Adjusted male Bladder Cancer Index urinary function by diversion type compared 
by age. 
 
 
 
 
 
 
 
Supplemental Figure 1:  
Ileal Conduit [blue], Indiana Pouch [red], Neobladder [green]. 
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Table 1. Patient, Pathological characteristics, and BCI outcomes 
 Neobladder 
(n=48) 
Ileal Conduit 
(n=44) 
Indiana Pouch 
(n=36) 
P-value 
Gender  <0.0001 
Male 
Female 
47 (98%) 35 (80%) 20 (56%) 
1 (2.1%) 9 (21%) 16 (44%) 
Stage  0.7606 
≤ pT1 
pT2 
pT3 
pT4 
30 (63%) 18 (40%) 21 (14%) 
9 (19%) 12 (28%) 6 (17%) 
7 (16%) 11 (26%) 7 (19%) 
2 (4.2%) 2 (4.7%) 2 (5.6%) 
Lymph node status  0.9408 
Positive 
Negative 
7 (15%) 6 (14%) 6 (17%) 
41 (85%) 37 (86%) 30 (83%) 
Age at surgery,  
Mean (SD) (16) 
58.4 (9.1) 67.2 (9.4) 61.8 (8.5) <0.0001 
Years from surgery 
to survey, Mean 
(SD)  
10.1 (3.3) 
 
10.8 (5.6) 
 
12.7 (5.6) 0.0513 
BCI, Mean (SD)  
Urinary function 50.1 (30.6) 79.5 (26.8) 81.6 (25.6) <0.0001 
Urinary bother 88.2 (14.7) 92.8 (8.9) 94.6 (7.2) 0.04 
Bowel function 82.6 (15.3) 79.9 (14.7) 80.0 (23.4) 0.74 
Bowel bother 90.5 (11.4) 89.7 (10.5) 84.8 (13.9) 0.11 
Sexual function 30.7 (25.8) 18.0 (21.7) 30.1 (28.4) 0.14 
Sexual bother 53.0 (26.8) 53.5 (32.5) 47.1 (30.8) 0.67 
 
 
 
 
Table 2. Analysis of covariance adjusting for gender, age at surgery, surgeon, 
and time from surgery to survey. 
 Neobladder Ileal 
Conduit 
Indiana 
Pouch 
 
Adjusted Means Mean SE Mean SE Mean SE P-value 
Urinary Function 55.3 7.1 80.4 6.2 84.4 5.7 0.0013* 
Urinary Bother 89.7 2.9 93.3 2.5 95.3 2.3 0.2400 
Bowel Function 74.1 4.4 78.0 3.6 77.3 3.5 0.7208 
Bowel Bother 90.5 3.0 90.4 2.4 86.3 2.4 0.3685 
Sexual Function 39.7 6.2 23.8 6.2 36.4 5.2 0.1017 
Sexual Bother 76.9 7.3 65.3 6.6 54.0 6.0 0.0387† 
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